Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07296887 · ClinicalTrials.gov registry record · NA
CARE Tool Study Aim 3
A NA study, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 430
- Enrollment target
NCT07296887: Recruiting NA study, sponsored by Washington University School of Medicine.
NCT07296887 is a NA study that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 430 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07296887, a NA study, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 430 participants
- Enrollment target
Study Summary
This study is a multi-site randomized trial to study the implementation of the CARE Tool and evaluate the CARE Tool. The CARE Tool is a web-based tool that gives people information about cancer care costs, health insurance, and resources to help with costs. Overall, the study aims to help patients with cancer overcome barriers they face navigating insurance and accessing financial resources.
Primary Outcome
COST will be calculated by the sum of 11-items according to the validated measure. The items are scored on a 5-point Likert scale as follows: 0-Not at all, 1-A little bit, 2-Somewhat, 3-Quite a bit, and 4-Very much. Total possible range is 0-44 and the lower the score indicates greater financial toxicity. Scores will be summarized using means and 95% confidence intervals. Changes between timepoints will be analyzed by a two-sample t-test.
Interventions
- OTHER Financial education information
- OTHER CARE Tool
- OTHER CARE Tool Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2026-04-08 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
What NCT07296887 shows while recruiting
NCT07296887 is an interventional study that assigns participants to a tested intervention. The registered 430 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 3 interventions - of which Financial education information is the first listed.
NCT07296887 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07296887 about?
NCT07296887 is a clinical study titled "CARE Tool Study Aim 3". This study is a multi-site randomized trial to study the implementation of the CARE Tool and evaluate the CARE Tool. The CARE Tool is a web-based tool that gives people information about cancer care costs, health insurance, and resources to help with costs. Overall, the study aims to help patients w...
What is the current status of trial NCT07296887?
This trial is currently recruiting. It is a NA study. The enrollment target is 430 participants. The study started on 2026-04-08. Estimated completion is 2028-07-31.
What interventions are being tested in trial NCT07296887?
The interventions under investigation include: Financial education information (OTHER), CARE Tool (OTHER), CARE Tool Training (OTHER).
Who is sponsoring clinical trial NCT07296887?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07296887's enrollment target sits among peer trials
430 235th of 2000 higher than 1,765 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05327023 · 430 participants · Phase 1
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- NCT05457985 · 430 participants · NA
Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers
- NCT05532982 · 430 participants
Parkinson's Disease in Asian Americans
- NCT05844891 · 430 participants · NA
Telehealth-Enhanced Asthma Care for Home After the Emergency Room
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI